VIICTR
Profiles
ORIT
Pediatrics RRO
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.
Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition. Clin Cancer Res. 2013 Aug 15; 19(16):4392-403.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Animals
Antibodies, Monoclonal, Humanized
Bevacizumab
Cell Line, Tumor
Disease Models, Animal
Drug Resistance, Neoplasm
Epithelial-Mesenchymal Transition
Female
Gene Expression Profiling
Glioblastoma
Humans
Mice
Myeloid Cells
Neoplasm Invasiveness
Neovascularization, Pathologic
Signal Transduction
Vascular Endothelial Growth Factor A
Xenograft Model Antitumor Assays
authors with profiles
JOHN FREDERICK DE GROOT
ERIK PHILIP SULMAN